Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
批准号:
10016378
负责人:
E. Albert Reece
金额:
$50.48万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2024-06-30
关键词:
AdultAgeAmericanApicalApoptosisCDKN1A geneCell Cycle ArrestCell ProliferationCellular StressCharacteristicsChildCultured CellsDNA DamageDevelopmentDiabetes MellitusDown-RegulationEmbryoEmbryonic DevelopmentEpigenetic ProcessEventExhibitsFOXO3A geneGenesHealthHumanIndividualInsulin-Dependent Diabetes MellitusKnockout MiceMediatingMediator of activation proteinMicroRNAsMolecularMusNeural FoldNeural Tube ClosureNeural Tube DefectsNeural tubeNeuroepithelialNeuroepithelial CellsNon-Insulin-Dependent Diabetes MellitusOrganOxidative StressOxidesPathway interactionsPhosphotransferasesPregnancy in DiabeticsPreventionReporterRoleSideSignal PathwaySignal TransductionStressStructural Congenital AnomaliesTeratogensTestingTranscription RepressorUp-RegulationWomandiabeticdiabetic embryopathygenomic locusimprovedinhibitor/antagonistmaternal diabetesneuroepitheliumnoveloffspringoverexpressionprematureprogramspromoterreproductiveresponsesenescencespecific biomarkerssuperoxide dismutase 1
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pregestational diabetes-induced neural tube defects (NTDs) remain a significant health problem. Kinase signaling-induced cellular stress is considered to be a causal event in NTD formation. However, the cause of stress-altered developmental programming relative to neurulation remains elusive. We found that both maternal type 1 and type 2 diabetes induce premature senescence in the developing neural tube. We also observed that deleting either the p21 gene or the p27 gene, the senescence mediators, ameliorates diabetes-induced NTD formation. Additionally, deletion of the microRNA-200c/141 (miR-200c/141) locus, which induces senescence in cultured cells, abolishes the increase of senescence mediators through the downregulation of the transcriptional repressor ZEB1 and ZEB2. Diabetes-increased miR-200c/141 expression is abrogated by superoxide dismutase 1 overexpression. Thus, we hypothesize that maternal diabetes induces premature senescence in proliferative cells of the developing neuroepithelium leading to failed neural fold fusion through up-regulation of miR-200c/141 by the oxidative stress-activated ASK1-FoxO3a pathway. miR-200c/141 up-regulates senescence mediators p21 and p27 through suppression of transcription repressors, ZEB1 and ZEB2. These senescence mediators arrest cell cycle progress of proliferative apical neuroepithelial cells leading to NTDs. Aim 1 will determine the characteristics of premature senescence during neurulation and whether diabetes-induced oxidative stress is the cause of senescence in diabetic pregnancy. We hypothesize that diabetes induces p21 expression specifically in the developing neuroepithelium leading to premature senescence in inhibiting neural fold fusion, and diabetes-induced oxidative stress is responsible for the induction of senescence in proliferative apical neuroepithelial cells. Aim 2 will investigate whether the oxidative stress-activated ASK1-FoxO3a pathway increases miR-200c/miR-141 that mediates maternal diabetes-induced premature senescence and NTDs. We will examine that diabetes induces miR-200c/141 through the ASK1-FoxO3a pathway, and that miR-200c/141 deletion suppresses p21 expression through liberating ZEB1/2 expression leading to inhibition of premature senescence and NTDs. Aim 3 will determine whether p21 and p27 induce cell cycle arrest in apical neuroepithelial cells leading to premature senescence and NTD formation in diabetic pregnancy. We will test the hypothesis that both p21 and p27 mediate cell cycle arrest and premature senescence in diabetic embryopathy, and that deletion of p21 and/or p27 ameliorates senescence and NTDs. We will continue to explore the role of key kinase signaling in senescence, a new developmental program, in diabetic embryopathy and to reveal how miRNAs participates in maternal diabetes-induced senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10267759
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10453652
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10676158
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10116005
-
项目类别:
-
资助金额:$58.69万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
The 15th Biennial Meeting of the Diabetes in Pregnancy Study Group North America
-
批准号:9398326
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2017
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:8856232
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10653120
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10189679
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:8767371
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10440363
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Construction Grant 8th Floor BRB
-
批准号:7839132
-
项目类别:
-
资助金额:$500.0万
-
财政年份:2010
-
负责人:E. Albert Reece
-
依托单位:
UMB Technology Resource Center
-
批准号:7935928
-
项目类别:
-
资助金额:$732.91万
-
财政年份:2010
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:8004693
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2009
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:8118807
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:7897889
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:7689344
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
General Clinical Research Center
-
批准号:7571693
-
项目类别:
-
资助金额:$236.88万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:7031759
-
项目类别:
-
资助金额:$248.93万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
General Clinical Research Center
-
批准号:7174523
-
项目类别:
-
资助金额:$241.71万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6622728
-
项目类别:
-
资助金额:$98.01万
-
财政年份:1999
-
负责人:E. Albert Reece
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: